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Summary 
Pleuropulmonary blastoma (PPB) in childhood is a rare clinicopathologic entity distinct 
from adult pneumoblastoma. This tumour may originate from the lung, the pleura, or the 
mediastinum; it can metastasize and is usually associated with a poor outcome. We report 
the case of a 5-year-old boy who developed PPB manifesting with respiratory distress. At 
the standard x-ray and magnetic resonance imaging of the chest there was opacity cover-
ing the entire right lung. The histological and immunohistological tests led to the diagno-
sis of blastematous, malignant mesenchymatous PPB with pluridirectional differentiation. 
Treatment consisted of preoperative chemotherapy to reduce tumour volume, complete 
surgical resection of the residuai tumour mass, and post-surgical chemotherapy. Following 
this approach, the child is alive in continuous complete remission 9 years after diagnosis. 
Riassunto 
II Blastoma Pleuro-Polmonare (BPP) infantile è un 'entità clinico patologica ben distinta 
dal Pneumoblastoma dell'adulto. Questo tumore può prendere origine dal polmone, dalla 
pleura o dal mediastino; può metastatizzare e ha spesso una prognosi infausta. Ripor-
tiamo il caso di un bambino di 5 anni, in cui il BPP si manifestò con un distress respi-
ratorio; la radiografia del torace e la Risonanza Magnetica hanno evidenziato una grossa 
massa che occupava l'emitorace destro. L'esame istopatologico ha permesso di porre 
diagnosi di BPP. Il paziente è stato trattato con chemioterapia, che ha ridotto il volume 
della massa, con asportazione del tumore e chemioterapia post-operatoria; tale tratta-
mento ha consentito i'eradicazione della malattia; il paziente è in remissione completa 
continua a 9 anni dalla diagnosi. 
Introduction 
Pleuropulmonary blastoma (PPB) is an extremely rare and aggressive malig-
nancy of childhood. It was originally described as a distinct entity by Maniv-
el et al. '. Prior to its identification it was reported in the early literature by 
Spencer as pulmonary blastoma or embryonic sarcoma 2. 
It is characterized by primitive mesenchymal tissue and epithelial tubular 
structures resembling the foetal lung. The eponymous PPB defines the paedi-
atric variety of pulmonary blastoma. In PPB, the dysembrionic neoplasm 
shows blastematous and sarcomatous components and a lack of carcinoma-
tous components (which are instead present in adult pulmonary blastoma), 
sometimes on previous dysplastic pulmonary conditions 3. PPB is classified 
in 3 subtypes: type I (cystic), type II (mixed solid and cystic) and type III 
(solid)4. 
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PLEUROPULMONARY BLASTOMA IN A CHILD 
The predominant clinical features are cough, tachyp-
nea, fever, respiratory distress; secondary pneumotho-
rax 5 and chest pain have also been reported 6. Since 
these features are not specific, an infectious disease is 
often erroneously diagnosed; hence, when eventually 
detected, the neoplasm is often very large, may even in-
volve an entire hemithorax, and present metastases. 
Despite the different therapeutic procedures - surgery, 
chemotherapy and radiotherapy - prognosis is often 
poor: Indolfi et al. 7 report 42% and Priest et al. 6 45% 
of event free survival (EFS) at 2 years. Poor prognostic 
factors are histological subtype II or III 6 , a maximum 
diameter greater than 5 cm 7 , failure to completely re-
move the mass, extrapulmonary effusion such as pleu-
ra or pericardium, metastases 8. 
We report the case of a five-year-old child who, despite 
the large tumour size at diagnosis and histological sub-
type II, after a treatment with chemotherapy before and 
after surgery, is in continuous complete remission 
(CCR) nine years after the diagnosis. 
Case report 
A 5-year-old boy was admitted to our ward for hy-
porexia, cough, shortness of breath, progressive thin-
ning and pallor in the previous 2 months. The physical 
examination showed poor clinical conditions, tachy-
dyspnea (R.F. 45/min.), hypophonesis and reduction of 
the physiologic vescicular murmure of the middle and 
lower regions of the right lung, meteoric abdomen with 
the liver margin 5 cm below the right costai margin. 
The results of the laboratory investigations were Hb 8.5 
g/dl, white blood cells 18.800/ul (N 68%, L 22%, M 
6%, E 4%), platelets 611.000/u.l, VES (K.I.) 65, CRP 
2.4 mg/dl; serum levels of copper 168 ixg/dl, ferritin 
292 ng/dl, L D H 1.261 u/1, oc-FP 6.3 u/1. 
Chest radiographs showed a bulky mass in the right 
hemithorax displacing the mediastinum leftward and 
the liver downward (Fig. 1). 
The thoracic-abdominal ultrasound scan showed a 
poorly confined voluminous mass, having diameters of 
120 x 86 mm, with echogenic-hyperechogenic struc-
ture and some hypo-anechogenic areas, arising in right 
hemithorax and displacing the liver and right kidney 
downwards. 
A magnetic resonance imaging (MRI) of the thorax 
showed a mass involving entirely the right hemitorax, 
with a centrai hemorrhagic component that displaced 
the mediastinum and the heart to the left. 
The patient underwent surgical thoracotomy, which re-
vealed an unencapsulated mass with smooth surface 
and tense-elastic consistency, entirely covered by pleu-
ra, not adherent to the thoracic wall; since the conspic-
uous extension of the mass did not allow resection, on-
ly a biopsy was performed. 
Microscopically, the biopsy specimen showed a pre-
dominantly solid neoplasm with focal cysts. The tu-
mour contained mesenchymal elongated cells arranged 
in sheets, and more primitive blastematous foci. There 
Fig. 1. Posterior-anterior chest radiograph at presentation, 
showing a bulky mass, displacing the mediastinum. 
was no evidence of typical rhabdomyoblasts or carti-
lage. Cysts exhibited an epithelial lining, with flattened 
to columnar cells and an underlying layer of primitive 
mesenchymal cells. The morphologic appearance was 
consistent with a diagnosis of PPB type II. Immunos-
tains emphasized the doublé component with a positive 
staining for cytokeratin (MNF116, pancytokeratin) in 
the epithelial component and a positive vimentin stain-
ing in mesenchymal component. Occasionai spindle 
cells were positive for desmin; oc-fetoprotein, S-100 
protein, CD99, NB84A were negative in both the ep-
ithelial and the stremai component. 
In order to stage the disease the patient underwent total 
body bone scan with "Tc-MDP, brain and abdominal 
CT scan, and bone marrow aspirate; no metastatic 
spread was detected, and a stage III was defined. 
The child underwent chemotherapy with carboplatinum 
(CBP) 400 mg/m2 + etoposide (VP16) 150 mg/m2 days 
1, 2; vincristine (VCR) 1.5 mg/m2 + actinomycin-D 
(ACT-D) 1.5 mg/m2 day 21 + ifosfamide (IFO) 1500 
mg/m2 days 21-23, for overall 3 cycles; thereafter, 2 cy-
cles were scheduled, including VCR 1.5 mg/m2 + ACT-
D 1.5 mg/m2 day 1, doxorubicin 40 mg/m2 days 1-2 and 
IFO 1500 mg/m2 days 1-3. The number of cycles were 
established according to the features of imaging stud-
ies. 
A chest x-ray survey showed a very good response 
(Fig. 2) to chemotherapy. Six months after the diagno-
sis complete resection of the tumour was performed 
through a right posterior-lateral thoracotomy by the 
fifth intercostal space. The tumour was capsulated and 
located between the upper and middle lobe of the right 
lung, displacing caudally the middle and lower pul-
monary lobes. The centrai zone of the mass was com-
posed of hyalinized fibrous stroma nodules and very 
small fragments of blastomatosous tumoral tissue, at 
about 2 cm from the resection borders. The neoplasm 
was almost entirely necrotic. 
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Fig. 2. Posterior-anterior chest radiograph, after chemotherapy, 
before surgical excision. 
After surgery the patient underwent 2 more cycles of 
chemotherapy with CBP 400 mg/m2 + VP 16 150 
mg/m2/day x 2 days. 
There was clinical and imaging evidence of a progres-
sive normalisation of lung morphology and function. 
The patient was monitored with clinical and radiologi-
cal investigations according to the following schedule: 
chest radiograms every 3 months the first year, every 6 
months the second and third year, every 12 months for 
the 4 t h, 5 l h and 6* year; MRI at 1 and 3 years after with-
drawal of therapy. 
Nine years after the diagnosis, the child is in continu-
ous complete remission. 
Discussion 
PPB in childhood is very rare. Our patient, as most of 
those reported in the literature 5 8, presented unspecific 
respiratory symptoms; the x-ray revealed a large in-
trathoracic mass, suggesting the need for further imag-
ing studies. It is important to emphasize the role of an 
early imaging examination (x-ray, ultrasound scan, CT 
or MRI) to detect as soon as possible the mass, in order 
to proceed to more specific investigations to elucidate 
the nature and staging of this malignant tumour. Radi-
ographic findings of pleuropulmonary blastoma are not 
specific, especially when most of the neoplasm is cys-
tic, resembling the radiographic features of teratoma. 
In this respect we note that PPB may initially manifest 
with clinical and radiologie signs and symptoms of 
pneumothorax 5 and may arise from other dysplastic 
conditions; as a matter of fact, cystic pulmonary ade-
nomatoid malformation (CPAM) can be associated 
with PPB, which is also described in association with 
some congenital dysembriogenic abnormalities as cys-
tic nephroma 3. The clinical and radiological presenta-
tion in our patient showed mediastinal involvement; 
the mass was not excisable at the first surgical look be-
cause the neoplasm involved the pleura and was very 
large. The histopathologic diagnosis was consistent 
with type II PPB. 
The features described usually correlate with a poor 
prognosis 6 8. The patient was submitted to intensive 
multiagent neoadiuvant chemotherapy, which reduced 
the tumour mass, making the complete surgical resec-
tion feasible, and allowing eradication of the malig-
nancy. 
Such intensive multiagent chemotherapy is in most cas-
es necessary for the reduction and complete excision of 
the tumor, which represents the most favourable factor 
for long term survival. 
In a recent report describing 11 patients 7, two under-
went total excision of the tumour at diagnosis, and 
were both alive without disease at 23 and 132 months 
respectively, with no adjuvant chemotherapy adminis-
tered in the latter; another 3 patients remained disease 
free, two after macroscopic total resection and poly-
chemotherapy and one after polychemotherapy and de-
layed complete surgery. 
The effectiveness of chemotherapy has also been re-
ported by other Authors 8 1 ° . The choice of the antiblas-
tic agents used in our patients was due to their known 
effectiveness on mesenchymal and epithelial tumors n . 
Our patient was not treated with radiotherapy, which 
has proven to be effective in few patients 1 . 
In conclusion, this case suggests that PPB may be tak-
en in consideration for the differential diagnosis in res-
piratory distress. According to our experience and to 
other literature reports, total remission of this condition 
may be achieved with complete surgical excision (pri-
mary or delayed) and intensive chemotherapy. 
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